Teleflex (TFX) Competitors $178.16 +3.37 (+1.93%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends TFX vs. DXCM, STE, PODD, HOLX, BAX, GMED, MASI, ITGR, IART, and ATRCShould you be buying Teleflex stock or one of its competitors? The main competitors of Teleflex include DexCom (DXCM), STERIS (STE), Insulet (PODD), Hologic (HOLX), Baxter International (BAX), Globus Medical (GMED), Masimo (MASI), Integer (ITGR), Integra LifeSciences (IART), and AtriCure (ATRC). These companies are all part of the "health care equipment" industry. Teleflex vs. DexCom STERIS Insulet Hologic Baxter International Globus Medical Masimo Integer Integra LifeSciences AtriCure DexCom (NASDAQ:DXCM) and Teleflex (NYSE:TFX) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, community ranking, dividends, analyst recommendations, earnings, media sentiment, institutional ownership and profitability. Is DXCM or TFX more profitable? DexCom has a net margin of 17.22% compared to Teleflex's net margin of 7.85%. DexCom's return on equity of 31.40% beat Teleflex's return on equity.Company Net Margins Return on Equity Return on Assets DexCom17.22% 31.40% 10.58% Teleflex 7.85%14.19%8.53% Do insiders and institutionals have more ownership in DXCM or TFX? 97.8% of DexCom shares are held by institutional investors. Comparatively, 95.6% of Teleflex shares are held by institutional investors. 0.3% of DexCom shares are held by insiders. Comparatively, 1.4% of Teleflex shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has stronger valuation & earnings, DXCM or TFX? DexCom has higher revenue and earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDexCom$3.95B7.91$541.50M$1.6747.93Teleflex$3.03B2.73$356.33M$5.0335.42 Does the media refer more to DXCM or TFX? In the previous week, DexCom had 4 more articles in the media than Teleflex. MarketBeat recorded 15 mentions for DexCom and 11 mentions for Teleflex. DexCom's average media sentiment score of 0.85 beat Teleflex's score of 0.52 indicating that DexCom is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DexCom 7 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Teleflex 2 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Does the MarketBeat Community prefer DXCM or TFX? DexCom received 449 more outperform votes than Teleflex when rated by MarketBeat users. Likewise, 71.72% of users gave DexCom an outperform vote while only 59.19% of users gave Teleflex an outperform vote. CompanyUnderperformOutperformDexComOutperform Votes97471.72% Underperform Votes38428.28% TeleflexOutperform Votes52559.19% Underperform Votes36240.81% Do analysts prefer DXCM or TFX? DexCom currently has a consensus price target of $98.00, indicating a potential upside of 22.44%. Teleflex has a consensus price target of $252.50, indicating a potential upside of 41.73%. Given Teleflex's higher probable upside, analysts clearly believe Teleflex is more favorable than DexCom.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DexCom 0 Sell rating(s) 6 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 2.72Teleflex 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.57 Which has more volatility & risk, DXCM or TFX? DexCom has a beta of 1.12, indicating that its stock price is 12% more volatile than the S&P 500. Comparatively, Teleflex has a beta of 1.16, indicating that its stock price is 16% more volatile than the S&P 500. SummaryDexCom beats Teleflex on 15 of the 19 factors compared between the two stocks. Ad Brownstone ResearchMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. Get Teleflex News Delivered to You Automatically Sign up to receive the latest news and ratings for TFX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TFX vs. The Competition Export to ExcelMetricTeleflexSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$8.27B$4.34B$5.12B$19.18BDividend Yield0.77%41.46%4.91%3.59%P/E Ratio35.4225.3791.3441.28Price / Sales2.7345.681,116.5917.59Price / Cash9.5743.4542.6421.28Price / Book1.897.364.795.32Net Income$356.33M$13.64M$120.07M$989.88M7 Day Performance-1.10%-2.80%-1.89%-3.54%1 Month Performance-6.48%0.56%11.45%-3.68%1 Year Performance-29.14%41.87%30.61%12.14% Teleflex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TFXTeleflex4.8981 of 5 stars$178.16+1.9%$252.50+41.7%-28.0%$8.27B$3.03B35.4214,500Analyst ForecastHigh Trading VolumeDXCMDexCom4.9166 of 5 stars$76.47-0.9%$98.00+28.2%-31.4%$29.87B$3.95B46.229,600STESTERIS4.9335 of 5 stars$212.73-0.7%$262.50+23.4%-3.5%$21.00B$5.14B48.9118,179Positive NewsPODDInsulet4.256 of 5 stars$264.61-1.8%$267.44+1.1%+28.2%$18.56B$1.70B46.123,000Positive NewsHOLXHologic4.7224 of 5 stars$72.81-1.1%$89.50+22.9%+1.9%$16.52B$4.03B22.147,063Analyst ForecastBAXBaxter International4.5387 of 5 stars$29.46-2.8%$40.45+37.3%-23.6%$15.04B$15.06B149.2060,000Options VolumeNews CoverageGMEDGlobus Medical4.8825 of 5 stars$82.17-0.3%$92.18+12.2%+59.4%$11.19B$2.48B122.675,000Analyst ForecastAnalyst RevisionMASIMasimo3.5649 of 5 stars$176.71+0.3%$170.67-3.4%+49.0%$9.46B$2.04B121.485,200Analyst ForecastITGRInteger2.8643 of 5 stars$138.73+0.0%$145.44+4.8%+36.4%$4.65B$1.71B43.0310,500Positive NewsIARTIntegra LifeSciences3.9777 of 5 stars$24.08+0.2%$23.00-4.5%-49.5%$1.86B$1.56B-267.003,946Positive NewsATRCAtriCure3.3562 of 5 stars$31.79+0.4%$42.00+32.1%-10.9%$1.55B$447.57M-38.161,200Analyst Forecast Related Companies and Tools Related Companies DexCom Alternatives STERIS Alternatives Insulet Alternatives Hologic Alternatives Baxter International Alternatives Globus Medical Alternatives Masimo Alternatives Integer Alternatives Integra LifeSciences Alternatives AtriCure Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:TFX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Teleflex Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Teleflex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.